chr11-20601520-C-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_004211.5(SLC6A5):āc.395C>Gā(p.Ala132Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00329 in 1,614,088 control chromosomes in the GnomAD database, including 188 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_004211.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A5 | NM_004211.5 | c.395C>G | p.Ala132Gly | missense_variant | 2/16 | ENST00000525748.6 | NP_004202.4 | |
SLC6A5 | NM_001318369.2 | c.-169C>G | 5_prime_UTR_variant | 2/15 | NP_001305298.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A5 | ENST00000525748.6 | c.395C>G | p.Ala132Gly | missense_variant | 2/16 | 1 | NM_004211.5 | ENSP00000434364.2 | ||
SLC6A5 | ENST00000298923.11 | n.395C>G | non_coding_transcript_exon_variant | 2/15 | 1 | ENSP00000298923.7 |
Frequencies
GnomAD3 genomes AF: 0.0173 AC: 2630AN: 152198Hom.: 92 Cov.: 34
GnomAD3 exomes AF: 0.00467 AC: 1166AN: 249908Hom.: 32 AF XY: 0.00359 AC XY: 486AN XY: 135398
GnomAD4 exome AF: 0.00183 AC: 2671AN: 1461772Hom.: 97 Cov.: 69 AF XY: 0.00160 AC XY: 1162AN XY: 727202
GnomAD4 genome AF: 0.0173 AC: 2637AN: 152316Hom.: 91 Cov.: 34 AF XY: 0.0168 AC XY: 1250AN XY: 74496
ClinVar
Submissions by phenotype
Hyperekplexia 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hyperekplexia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
SLC6A5-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 13, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at